Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Oncology Letters|October 3, 2025
Discoidin domain receptor tyrosine kinase 2: A new perspective on microenvironment remodeling and targeted therapy of solid tumors (Review)Tong Lu, Huiying Guo, Hang Gong, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|May 23, 2022
[Research progress of targeting macrophage surface receptors in the treatment of inflammatory bowel disease]Ludan Zhang, Huimei Xu, Tianyi Wang, et al.
BMC Medical Genomics|June 5, 2023
Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric CancerHuimei Xu, Ke Huang, Yimin Lin, et al.
Current Molecular Pharmacology|February 22, 2023
DDR1-Induced Paracrine Factors of Hepatocytes Promote HSC Activation and Fibrosis DevelopmentYing Meng, Tong Zhao, Tiyun Han, et al.
Frontiers in Microbiology|April 3, 2023
A review on the research progress on non-pharmacological therapy of <i>Helicobacter pylori</i>Qian Luo, Na Liu, Sugui Pu, et al.
3 Biotech|November 6, 2019
Antimicrobial potential of endophytic fungi from <i>Astragalus chinensis</i>Peiji Liu, Dekui Zhang, Ruirui Shi, et al.
Oncology Research and Treatment|October 25, 2021
Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric CancerMuyang Li, Wenshan Dou, Yimin Lin, et al.
Pharmaceutical Biology|May 13, 2021
Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in miceLong Cheng, Xiaoying Wang, Xueni Ma, et al.
International Journal of Pharmaceutics|January 2, 2025
Dihydromyricetin/montmorillonite intercalation compounds ameliorates DSS-induced colitis: Role of intestinal epithelial barrier, NLRP3 inflammasome pathway and gut microbiotaLuxia Jiang, Xueni Ma, Qi Yan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 2, 2023
Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathwayXiaoChun Wang, XiaoLi Li, XueNi Ma, et al.
Pageof 11